Replies to post #377429 on Elite Pharmaceuticals Inc (ELTP)

[imanjen13]

Institutions and insiders control almost 75% of Lannetts shares so comparison is questionable. I would expect that a 25% move here to a nickel would not surprise or excite most investors and that price would require a 1 for 50 to support a $2.50 Nasdaq qualifying price.

While a reverse split will be necessary, NH believes it should be done after the market recognizes the intrinsic value and prices the stovk at a higher price. If price was .15-.25 cents, he could reverse at 1 for 10 which would be acceptable to me and I believe most shareholders.

[Sctrben]

We show our sht is coming together and we’ll do all that and more without the reverse….. then he can pull the cord on that process, we’re not an exciting company right now, I believe we’re a gem, but have some things ahead that need getting done. Proof April 1 that work has been done already on marketing platform for distribution accounts, (in place, signed contracts). Not starting to work on, talking to, potential, yada yada, but real work done…